Mark Kaganovich

CEO of SolveBio


Cofactor will automatically discover the description of this topic and display it here.


“There are other companies and hospitals working on ways to interpret the genome. However, no one that we are aware of is working on better ways to deliver and distribute the content necessary to make these interpretations happen. We’re the only ones focusing on making the jobs of developers easier in this field,” SolveBio’s CEO and co-founder Mark Kaganovich said in an email.

See also

See also: